• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国血液透析血管通路的发病率

Hemodialysis vascular access morbidity in the United States.

作者信息

Feldman H I, Held P J, Hutchinson J T, Stoiber E, Hartigan M F, Berlin J A

机构信息

University of Pennsylvania School of Medicine, Philadelphia.

出版信息

Kidney Int. 1993 May;43(5):1091-6. doi: 10.1038/ki.1993.153.

DOI:10.1038/ki.1993.153
PMID:8510387
Abstract

Extensive morbidity related to hemodialysis vascular access exists among end-stage renal disease (ESRD) patients, but the risk factors for this morbidity have not been extensively studied. Medicare ESRD patient data were obtained from 1984, 1985, and 1986. Hospitalization for vascular access morbidity (ICD-996.1, 996.6, or 996.7) was analyzed among prevalent patients and, using survival analysis, among incident patients to assess sex, age, race, and underlying cause of renal failure as risk factors. We found that 15 to 16% of hospital stays among prevalent ESRD patients were associated with vascular access-related morbidity. Black race, older age, female sex, and diabetes mellitus as a cause of kidney failure were all independent risk factors for access-related morbidity. The rate ratio comparing Blacks to Whites was 1.12 (95% C.I., 1.09, 1.16); > 64 years to 20 to 44 years, 1.53 (1.46, 1.59); men to women, 0.81 (0.79, 0.84); and diabetes to glomerulonephritis, 1.29 (1.24, 1.35). We conclude that hemodialysis vascular access malfunction causes much hospitalization among ESRD patients. Women, Blacks, the elderly, and diabetics appear to be at particularly high risk, and additional studies are needed to understand these patterns.

摘要

终末期肾病(ESRD)患者中存在与血液透析血管通路相关的大量发病情况,但对此类发病的危险因素尚未进行广泛研究。医疗保险ESRD患者数据取自1984年、1985年和1986年。对现患患者中因血管通路发病而住院(国际疾病分类第九版编码996.1、996.6或996.7)的情况进行了分析,并采用生存分析方法对新发病例患者进行分析,以评估性别、年龄、种族和肾衰竭的潜在病因作为危险因素。我们发现,ESRD现患患者中15%至16%的住院与血管通路相关发病有关。黑人种族、高龄、女性以及糖尿病作为肾衰竭病因均是与通路相关发病的独立危险因素。黑人与白人的率比为1.12(95%置信区间为1.09至1.16);64岁以上与20至44岁相比,为1.53(1.46至1.59);男性与女性相比,为0.81(0.79至0.84);糖尿病与肾小球肾炎相比,为1.29(1.24至1.35)。我们得出结论,血液透析血管通路故障在ESRD患者中导致大量住院情况。女性、黑人、老年人和糖尿病患者似乎风险尤其高,需要进一步研究以了解这些模式。

相似文献

1
Hemodialysis vascular access morbidity in the United States.美国血液透析血管通路的发病率
Kidney Int. 1993 May;43(5):1091-6. doi: 10.1038/ki.1993.153.
2
Correlates of vascular access and nonvascular access-related hospitalizations in hemodialysis patients.血液透析患者血管通路及非血管通路相关住院的影响因素
Am J Nephrol. 1996;16(2):118-23. doi: 10.1159/000168982.
3
Survival differences among older dialysis patients in the southeast.东南部老年透析患者的生存差异。
Am J Kidney Dis. 1992 Oct;20(4):376-86. doi: 10.1016/s0272-6386(12)70302-5.
4
Determinants of type of initial hemodialysis vascular access.初始血液透析血管通路类型的决定因素
Am J Nephrol. 1997;17(5):425-7. doi: 10.1159/000169135.
5
Relation between gender and vascular access complications in hemodialysis patients.血液透析患者性别与血管通路并发症之间的关系。
Am J Kidney Dis. 2000 Dec;36(6):1126-34. doi: 10.1053/ajkd.2000.19816.
6
Septicemia in dialysis patients: incidence, risk factors, and prognosis.透析患者的败血症:发病率、危险因素及预后。
Kidney Int. 1999 Mar;55(3):1081-90. doi: 10.1046/j.1523-1755.1999.0550031081.x.
7
Factors Associated With Withdrawal From Maintenance Dialysis: A Case-Control Analysis.与维持性透析退出相关的因素:病例对照分析。
Am J Kidney Dis. 2018 Jun;71(6):831-841. doi: 10.1053/j.ajkd.2017.10.025. Epub 2018 Jan 10.
8
National profile of practice patterns for hemodialysis vascular access in the United States.美国血液透析血管通路的全国实践模式概况
J Am Soc Nephrol. 2002 Aug;13(8):2117-24. doi: 10.1097/01.asn.0000022422.79790.a8.
9
The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis.慢性肾脏病、终末期肾病以及透析第一年的发病率和死亡率状况。
Clin J Am Soc Nephrol. 2009 Dec;4 Suppl 1:S5-11. doi: 10.2215/CJN.05980809.
10
Patterns of care for patients with chronic kidney disease in the United States: dying for improvement.美国慢性肾病患者的护理模式:为改善而亡。
J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S76-80. doi: 10.1097/01.asn.0000070145.00225.ec.

引用本文的文献

1
Prediction of Arteriovenous Access Dysfunction by Mel Spectrogram-based Deep Learning Model.基于梅尔频谱的深度学习模型预测动静脉内瘘功能障碍
Int J Med Sci. 2024 Aug 19;21(12):2252-2260. doi: 10.7150/ijms.98421. eCollection 2024.
2
Cannulation Technique of Vascular Access in Hemodialysis and the Impact on the Arteriovenous Fistula Survival: Systematic Review and Meta-Analysis.血液透析中血管通路的插管技术及其对动静脉内瘘存活的影响:系统评价和荟萃分析
J Clin Med. 2023 Sep 13;12(18):5946. doi: 10.3390/jcm12185946.
3
A Comparative Study of Continuous Versus Interrupted Suturing Technique in Creating a Vascular Access for Hemodialysis: An Institutional-Based Experience.
连续缝合技术与间断缝合技术在建立血液透析血管通路中的比较研究:基于机构的经验
Cureus. 2023 Jul 17;15(7):e42004. doi: 10.7759/cureus.42004. eCollection 2023 Jul.
4
A randomised control trial protocol of MuST for vascular access cannulation in hemodialysis patients (MuST Study): contributions for a safe nursing intervention.MuST 用于血液透析患者血管通路置管的随机对照试验方案(MuST 研究):为安全护理干预提供的贡献。
BMC Nephrol. 2022 Jun 21;23(1):218. doi: 10.1186/s12882-022-02842-3.
5
The outcome of radiocephalic after brachiocephalic and redo arteriovenous fistula.头臂型动静脉内瘘及再次动静脉内瘘术后桡动脉头静脉内瘘的结局
SAGE Open Med. 2022 Jan 21;10:20503121211069280. doi: 10.1177/20503121211069280. eCollection 2022.
6
Cannulation Technique of Vascular Access in Haemodialysis and the Impact on the Arteriovenous Fistula Survival: Protocol of Systematic Review.血液透析中血管通路的插管技术及其对动静脉内瘘存活的影响:系统评价方案
Int J Environ Res Public Health. 2021 Nov 29;18(23):12554. doi: 10.3390/ijerph182312554.
7
Nitric oxide releasing nanomatrix gel treatment inhibits venous intimal hyperplasia and improves vascular remodeling in a rodent arteriovenous fistula.释放一氧化氮的纳米基质凝胶治疗可抑制啮齿动物动静脉瘘中的静脉内膜增生并改善血管重塑。
Biomaterials. 2022 Jan;280:121254. doi: 10.1016/j.biomaterials.2021.121254. Epub 2021 Nov 18.
8
Comparable Patency of Open and Hybrid Treatment of Venous Anastomotic Lesions in Thrombosed Haemodialysis Grafts.血栓形成的血液透析移植物吻合口病变的开放和杂交治疗的可比性通畅率。
Eur J Vasc Endovasc Surg. 2020 Dec;60(6):897-903. doi: 10.1016/j.ejvs.2020.08.012. Epub 2020 Sep 11.
9
Challenges and novel therapies for vascular access in haemodialysis.血液透析血管通路的挑战和新疗法。
Nat Rev Nephrol. 2020 Oct;16(10):586-602. doi: 10.1038/s41581-020-0333-2. Epub 2020 Aug 24.
10
Association Between Type of Vascular Access Used in Hemodialysis Patients and Subsequent Kidney Transplant Outcomes.血液透析患者使用的血管通路类型与后续肾移植结果之间的关联。
Kidney Med. 2019 Oct 25;1(6):383-390. doi: 10.1016/j.xkme.2019.08.005. eCollection 2019 Nov-Dec.